Showing results (171-180 of 447) with videos related to
Sort By:
Pageof 45
Proceedings of the National Academy of Sciences of the United States of America|July 18, 2008
Genomic markers for malignant progression in pulmonary adenocarcinoma with bronchioloalveolar featuresSarit Aviel-Ronen, Bradley P Coe, Suzanne K Lau, et al.Journal for Immunotherapy of Cancer|January 24, 2019
Human double negative T cells target lung cancer via ligand-dependent mechanisms that can be enhanced by IL-15Junlin Yao, Dalam Ly, Dzana Dervovic, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|January 18, 2018
Use of multicolor fluorescence in situ hybridization to detect deletions in clinical tissue sectionsMaisa Yoshimoto, Olga Ludkovski, Jennifer Good, et al.Journal of Biophotonics|January 18, 2023
Wide-field Stokes polarimetric microscopy for second harmonic generation imagingLeonardo Uribe Castaño, Kamdin Mirsanaye, Lukas Kontenis, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|March 10, 2018
Correction to: Use of multicolor fluorescence in situ hybridization to detect deletions in clinical tissue sectionsMaisa Yoshimoto, Olga Ludkovski, Jennifer Good, et al.Proceedings of the National Academy of Sciences of the United States of America|January 14, 2009
TAp73 regulates the spindle assembly checkpoint by modulating BubR1 activityRichard Tomasini, Katsuya Tsuchihara, Chiharu Tsuda, et al.Lung Cancer (Amsterdam, Netherlands)|March 20, 2019
A study of ALK-positive pulmonary squamous-cell carcinoma: From diagnostic methodologies to clinical efficacyHaiyue Wang, Leina Sun, Yaxiong Sang, et al.Cancers|July 31, 2020
Circulating miR-16-5p, miR-92a-3p, and miR-451a in Plasma from Lung Cancer Patients: Potential Application in Early Detection and a Regulatory Role in Tumorigenesis PathwaysPatricia P Reis, Sandra A Drigo, Robson F Carvalho, et al.The Journal of Clinical Investigation|September 14, 2011
TRAF6 is an amplified oncogene bridging the RAS and NF-κB pathways in human lung cancerDaniel T Starczynowski, William W Lockwood, Sophie Deléhouzée, et al.Lung Cancer (Amsterdam, Netherlands)|August 6, 2021
The rapidly evolving landscape of novel targeted therapies in advanced non-small cell lung cancerBarbara Melosky, Paul Wheatley-Price, Rosalyn A Juergens, et al.Pageof 45